This AI Could Predict Disease Decades Early | Dr. Wei-Wu He on Genomics & Longevity

Hosts: Phil Newman: https://qrco.de/bgXpNY Nina Patrick: ⁠⁠https://qrco.de/bgXpKn ---------- Sponsor: FlexBeam FlexBeam is a wearable red light therapy system that brings targeted support directly to where you need it most. Lightweight, portable, and easy to use, it fits naturally into your daily routine, making recovery and self-care more accessible whether you're at home, traveling, or between activities. Click the link below to learn more and use code LONGEVITY.TECHNOLOGY for 10% off. Link: https://rechargehealthas.sjv.io/jRQyQ5 ---------- Guests: Wei-Wu He Chairman and CEO, Human Longevity, Inc. LinkedIn:   / wei-wu-he-ph-d-he-him-b6957313   Website: https://www.humanlongevity.com/ ---------- What if the future of medicine isn't about treating disease, but predicting it years before symptoms ever appear? Phil Newman and Dr. Nina Patrick sit down with Dr. Wei-Wu He, CEO and Executive Chairman of Human Longevity Inc. (HLI), to explore how genomics, AI, multiomics, and precision medicine are converging to create an entirely new model of healthcare. A longtime entrepreneur, investor, and advocate for longevity science, Wei-Wu shares how HLI has evolved from one of the world's most ambitious genomics projects into a global precision health platform focused on disease prevention, risk prediction, and personalized intervention. The conversation explores why genome sequencing may become one of the most important medical tools of the next decade, and why Dr. He believes every person should have access to their genomic data. He explains how advances in AI are making it possible to interpret vast amounts of biological information, turning genome sequences, imaging scans, blood biomarkers, and longitudinal health records into actionable insights that can guide both patients and physicians. Wei-Wu also discusses HLI's collaboration with Insilico Medicine to build AI-powered foundation models for longevity and disease prediction, the importance of diverse global datasets, and why population-specific genomic algorithms may outperform one-size-fits-all approaches developed from Western biobanks alone. The discussion expands beyond technology to explore the broader future of healthcare. Why are countries like China, the UAE, and Singapore moving aggressively into genomic medicine? What role will governments, insurers, and healthcare systems play in making prevention more accessible? And how close are we to a world where AI-powered health guidance becomes a routine part of everyday medical care? In this episode, you’ll learn: Why recent research suggests genetics may account for roughly 50% of lifespan variation How whole genome sequencing is becoming dramatically more affordable and accessible Why AI may outperform human experts in specific diagnostic tasks Why pancreatic cancer outcomes depend heavily on stage-zero and stage-one detection Why China, the UAE, and other countries are investing heavily in genomic healthcare How longevity clinics may evolve into mainstream healthcare over the coming decade If you want to understand how AI, genomics, and longitudinal health data may transform medicine, this episode connects cutting-edge science with practical strategies for extending healthspan. Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better. ---------- Timestamps: 00:00:00 - Welcome To The Future 00:02:16 - A New Medical Era 00:03:00 - US Vs China 00:04:28 - Reinventing Human Longevity 00:09:39 - The $599 Genome 00:12:15 - Can Data Change Behavior? 00:17:39 - AI Meets Longevity 00:23:09 - Predicting Heart Attacks 00:27:20 - China’s Prevention Advantage 00:35:14 - Bringing Genomics To Consumers 00:37:10 - The Million-Dollar Pledge 00:45:56 - Can Clinics Scale? 00:48:47 - Standards For Longevity 00:54:10 - Rapid Fire Insights 01:00:07 - When Longevity Goes Mainstream